These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
552 related articles for article (PubMed ID: 31268163)
1. Receptor tyrosine kinase, RON, promotes tumor progression by regulating EMT and the MAPK signaling pathway in human oral squamous cell carcinoma. Kim SA; Lee KH; Lee DH; Lee JK; Lim SC; Joo YE; Chung IJ; Noh MG; Yoon TM Int J Oncol; 2019 Aug; 55(2):513-526. PubMed ID: 31268163 [TBL] [Abstract][Full Text] [Related]
2. Neuropilin-1 promotes epithelial-to-mesenchymal transition by stimulating nuclear factor-kappa B and is associated with poor prognosis in human oral squamous cell carcinoma. Chu W; Song X; Yang X; Ma L; Zhu J; He M; Wang Z; Wu Y PLoS One; 2014; 9(7):e101931. PubMed ID: 24999732 [TBL] [Abstract][Full Text] [Related]
3. Expression of the receptor tyrosine kinase recepteur d'origine nantais and its association with tumor progression in hypopharyngeal cancer. Yoon TM; Kim SA; Park YL; Lee KH; Sung MW; Lee JK; Lim SC; Chung IJ; Joo YE Head Neck; 2013 Aug; 35(8):1106-13. PubMed ID: 22887469 [TBL] [Abstract][Full Text] [Related]
4. RON is associated with tumor progression via the inhibition of apoptosis and cell cycle arrest in human gastric cancer. Song YA; Park YL; Kim KY; Myung E; Chung CY; Cho SB; Lee WS; Jung YD; Kweon SS; Joo YE Pathol Int; 2012 Feb; 62(2):127-36. PubMed ID: 22243783 [TBL] [Abstract][Full Text] [Related]
5. Suppression of miR-204 enables oral squamous cell carcinomas to promote cancer stemness, EMT traits, and lymph node metastasis. Yu CC; Chen PN; Peng CY; Yu CH; Chou MY Oncotarget; 2016 Apr; 7(15):20180-92. PubMed ID: 26933999 [TBL] [Abstract][Full Text] [Related]
6. RON (recepteur d'origine nantais) expression and its association with tumor progression in laryngeal squamous cell carcinoma. Kim SA; Yoon TM; Lee DH; Park YL; Lee KH; Lim SC; Joo YE; Lee JK Auris Nasus Larynx; 2014 Apr; 41(2):201-6. PubMed ID: 24287326 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA‑199a‑5p suppresses migration and invasion in oral squamous cell carcinoma through inhibiting the EMT‑related transcription factor SOX4. Wei D; Wang W; Shen B; Zhou Y; Yang X; Lu G; Yang J; Shao Y Int J Mol Med; 2019 Jul; 44(1):185-195. PubMed ID: 31059001 [TBL] [Abstract][Full Text] [Related]
8. STAT3-induced upregulation of long noncoding RNA HNF1A-AS1 promotes the progression of oral squamous cell carcinoma via activating Notch signaling pathway. Liu Z; Li H; Fan S; Lin H; Lian W Cancer Biol Ther; 2019; 20(4):444-453. PubMed ID: 30404566 [TBL] [Abstract][Full Text] [Related]
9. Small interfering RNA-directed targeting of RON alters invasive and oncogenic phenotypes of human hepatocellular carcinoma cells. Cho SB; Park YL; Song YA; Kim KY; Lee GH; Cho DH; Myung DS; Park KJ; Lee WS; Chung IJ; Choi SK; Kim KK; Joo YE Oncol Rep; 2011 Dec; 26(6):1581-6. PubMed ID: 21874262 [TBL] [Abstract][Full Text] [Related]
10. MUC1 gene silencing inhibits proliferation, invasion, and migration while promoting apoptosis of oral squamous cell carcinoma cells. Zhang AM; Chi XH; Bo ZQ; Huang XF; Zhang J Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31439759 [TBL] [Abstract][Full Text] [Related]
11. Knockdown of IFI27 inhibits cell proliferation and invasion in oral squamous cell carcinoma. Wang H; Qiu X; Lin S; Chen X; Wang T; Liao T World J Surg Oncol; 2018 Mar; 16(1):64. PubMed ID: 29580248 [TBL] [Abstract][Full Text] [Related]
12. Recepteur d'origine nantais contributes to the development of endometriosis via promoting epithelial-mesenchymal transition of a endometrial epithelial cells. Yu Q; Wang J; Li T; Guo X; Ding S; Che X; Zhu L; Peng Y; Xu X; Zou G; Zhang X J Cell Mol Med; 2021 Feb; 25(3):1601-1612. PubMed ID: 33410267 [TBL] [Abstract][Full Text] [Related]
13. NDRG1 deficiency is associated with regional metastasis in oral cancer by inducing epithelial-mesenchymal transition. de Lima JM; Morand GB; Macedo CCS; Diesel L; Hier MP; Mlynarek A; Kowalski LP; Maschietto M; Alaoui-Jamali MA; da Silva SD Carcinogenesis; 2020 Jul; 41(6):769-777. PubMed ID: 32112078 [TBL] [Abstract][Full Text] [Related]
14. miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling. Lu M; Wang C; Chen W; Mao C; Wang J DNA Cell Biol; 2018 Apr; 37(4):381-388. PubMed ID: 29364705 [TBL] [Abstract][Full Text] [Related]
15. CD47-SIRPα Signaling Induces Epithelial-Mesenchymal Transition and Cancer Stemness and Links to a Poor Prognosis in Patients with Oral Squamous Cell Carcinoma. Pai S; Bamodu OA; Lin YK; Lin CS; Chu PY; Chien MH; Wang LS; Hsiao M; Yeh CT; Tsai JT Cells; 2019 Dec; 8(12):. PubMed ID: 31861233 [TBL] [Abstract][Full Text] [Related]
16. ERK-mediated upregulation of matrix metalloproteinase-2 promotes the invasiveness in human oral squamous cell carcinoma (OSCC). Pramanik KK; Mishra R Exp Cell Res; 2022 Feb; 411(1):112984. PubMed ID: 34951997 [TBL] [Abstract][Full Text] [Related]
17. Involvement of recepteur d'origine nantais receptor tyrosine kinase in Epstein-Barr virus-associated nasopharyngeal carcinoma and its metastasis. Chou YC; Chen CL; Yeh TH; Lin SJ; Chen MR; Doong SL; Lu J; Tsai CH Am J Pathol; 2012 Nov; 181(5):1773-81. PubMed ID: 22974584 [TBL] [Abstract][Full Text] [Related]
18. Bovine lactoferrin reverses programming of epithelial-to-mesenchymal transition to mesenchymal-to-epithelial transition in oral squamous cell carcinoma. Chea C; Miyauchi M; Inubushi T; Okamoto K; Haing S; Nguyen PT; Imanaka H; Takata T Biochem Biophys Res Commun; 2018 Dec; 507(1-4):142-147. PubMed ID: 30415774 [TBL] [Abstract][Full Text] [Related]
19. Chemokine (CC motif) ligand 18 upregulates Slug expression to promote stem-cell like features by activating the mammalian target of rapamycin pathway in oral squamous cell carcinoma. Wang H; Liang X; Li M; Tao X; Tai S; Fan Z; Wang Z; Cheng B; Xia J Cancer Sci; 2017 Aug; 108(8):1584-1593. PubMed ID: 28574664 [TBL] [Abstract][Full Text] [Related]
20. CMTM3 inhibits cell growth and migration and predicts favorable survival in oral squamous cell carcinoma. Zhang H; Zhang J; Nan X; Li X; Qu J; Hong Y; Sun L; Chen Y; Li T Tumour Biol; 2015 Sep; 36(10):7849-58. PubMed ID: 25946973 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]